计算溶液所需的质量、体积或浓度。
提供 ≥99% 纯度,适用于对基线干扰要求严格的色谱和分析工作流程。
-20°C储存。超低温运输 。请查阅批次 COA 获取详细规格。
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
在色谱分析、有机合成和交叉偶联反应领域已被 0 篇同行评审文献引用。
Deutenzalutamide (Enzalutamide-d 3 ) is a developed deuterium labeled Enzalutamide (MDV3100). Enzalutamide is an androgen receptor (AR) antagonist with an IC50 of 36 nM in LNCaP prostate cells.
In Vitro
Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs. Potential advantages of deuterated compounds: (1) Extend the half-life in vivo. Deuterated compounds may be able to prolong the pharmacokinetic characteristics of the compound, that is, prolong the half-life in vivo. This can improve compound safety, efficacy and tolerability, and increase ease of administration. (2) Improve oral bioavailability. Deuterated compounds may reduce the degree of unwanted metabolism (first-pass metabolism) in the gut wall and liver, allowing a greater proportion of the unmetabolized drug to reach its target site of action. High bioavailability determines its activity at low doses and better tolerance. (3) Improve metabolic characteristics. Deuterated compounds may reduce the formation of toxic or reactive metabolites and improve drug metabolism. (4) Improve drug safety. Deuterated compounds may reduce or eliminate adverse side effects of pharmaceutical compounds and are safe. (5) Preserve the therapeutic properties. Deuterated compounds are expected to retain similar biochemical potency and selectivity to hydrogen analogs in previous studies. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Form:Solid
分类树(Taxonomy Tree)
| 界(kingdom) | 有机化合物 |
|---|---|
| 超类(Superclass) | 有机杂环化合物 |
| 类(Class) | 唑烷类 |
| 亚类(Subclass) | 咪唑烷类 |
| 中间层级节点(Intermediate Tree Nodes) | 暂无 |
| 直接上位类(Direct Parent) | 苯基咪唑烷类 |
| 其他上位类(Alternative Parents) | 三氟甲基苯 2-卤苯甲酸及其衍生物 α氨基酸及其衍生物 N-苯基硫脲 苯甲酰胺类 苯甲酰衍生物 苯腈 氟苯类 咪唑啉酮类 芳基氟化物 乙烯基卤化物 硫脲类 仲羧酸酰胺 腈类 氮杂环化合物 羰基化合物 碳氢化合物衍生物 有机氧化物 烷基氟化物 有机氟化物 |
| 分子骨架(Molecular Framework) | 芳香族杂单环化合物 |
| 取代基(Substituents) | 2-呋喃酮 - 氟化烷基 - 烷基溴化物 - α-氨基酸或其衍生物 - 芳香族杂单环化合物 - 芳基氟化物 - 芳基卤化物 - 氮杂环 - 苯甲酰胺 - 苯基化合物 - 苯甲酸或衍生物 - 苯甲腈 - 苯甲酰 - 碳腈 - 羰基 - 羧酰胺基 - 羧酸衍生物 - 氰化物 - 氟萘 - 卤苯 - 卤代苯甲酸或其衍生物 - 烃衍生物 - 咪唑烷酮 - 单环苯基基团 - N-甲基吡啶鎓 - 氰基化合物 - 有机硝基化合物 - 有机氧化物 - 有机氧化合物 - 有机氟化物 - 有机卤化物 - 有机氮化合物 - 有机氧化合物 - 有机硫化合物 - 苯基咪唑烷 - 醛基 - 硫代脲 - 三氟甲基苯 - 乙烯醯基鹵化物 |
| 描述(Description) | 该化合物属于苯基咪唑烷类有机化合物。这类多环化合物含有被苯基取代的咪唑啉结构。 |
| 外部描述符(External Descriptors) | 暂无 |